Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

HUTCHMED (China) Limited (0013.HK) Technical Analysis - StockMarketCap

Stocks›HUTCHMED (China) Limited☆

● At closeAs of Jul 2, 2026

HUTCHMED (China) Limited

HKG: 0013✓

HealthcareDrug Manufacturers - Specialty & GenericHKSE

$2.24HK$17.60+4.89%

$1.93BMarket cap

-P/E ratio

5.85MVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$2.24HK$17.60

$0.10 (+4.89%) · 24h

Key metrics

Market cap$1.93B-5.43%

Enterprise value$1.93B

Volume (24h)5.85M

P/E ratio (TTM)-

P/S ratio (TTM)-

Dividend yield-

Shares outstanding859.75M

Trading range

Previous closeHK$16.78

Day rangeHK$17.14 - HK$17.85

52-week range-

HUTCHMED (China) Limited (0013.HK) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector, listed on HKSE.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Technical summary

Strong buy

5 buy3 neutral0 sell

Aggregated from 5 moving averages and 3 oscillators. Educational only, not advice.

Relative Strength Index (14)

53.9

OversoldNeutralOverbought

Moving averages

SMA 2016.85Buy

SMA 50-Neutral

SMA 200-Neutral

EMA 1216.75Buy

EMA 2617.32Buy

Oscillators

RSI (14)53.9Neutral

MACD (12,26,9)-0.57Buy

Momentum (10d)1.05Buy

52-week range

$15.5735% of range$21.32

Monthly returns

Sign in to see the full technical analysis

Create a free account to unlock moving averages, RSI, MACD, and the buy/sell summary.

By continuing you agree to our Terms and Privacy Policy.

Free account. No credit card required.